ZNF425, as a zinc finger protein, is intricately involved in the regulation of gene expression through its DNA-binding capability. The chemicals listed are not direct activators of ZNF425 but rather influence its activity or expression indirectly by targeting key cellular processes like DNA methylation, histone modification, and zinc homeostasis. Compounds such as 5-Azacytidine and RG108, which inhibit DNA methyltransferases, can alter the epigenetic landscape, potentially affecting the transcriptional regulation activities of ZNF425. Histone deacetylase (HDAC) inhibitors like Trichostatin A and SAHA modify chromatin structure, which can have downstream effects on ZNF425-mediated gene expression.
Additionally, the function of zinc finger proteins like ZNF425 is closely tied to zinc availability, and compounds that modulate zinc levels, such as Disulfiram and Pyrithione Zinc, may indirectly impact ZNF425 activity. Furthermore, inhibitors of histone acetyltransferases (e.g., C646) and histone methyltransferases (e.g., BIX-01294) can also affect the expression and function of genes regulated by ZNF425. Mithramycin A, with its DNA-binding ability, could compete with ZNF425 for DNA binding sites, influencing its regulatory roles.
JQ1 and DZNep target other aspects of chromatin accessibility and gene expression, further illustrating the complex interplay between various epigenetic modifiers and zinc finger proteins like ZNF425. Genistein's broad impact on signal transduction pathways can also have indirect effects on the transcriptional regulatory functions of ZNF425.
These chemical compounds provide valuable tools for studying the biological functions and regulatory mechanisms associated with ZNF425. By influencing the epigenetic and transcriptional landscape in which ZNF425 operates, they offer insights into the broader context of gene regulation and the intricate network of interactions that govern cellular processes. Such understanding is crucial for unraveling the complex roles of zinc finger proteins in gene expression and cellular function.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | ¥3159.00 | 4 | |
DNA 甲基转移酶抑制剂 5-氮杂胞苷可能通过改变 DNA 甲基化模式间接影响 ZNF425,从而影响基因表达。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | ¥1681.00 ¥5303.00 ¥6995.00 ¥13527.00 ¥23579.00 | 33 | |
HDAC 抑制剂 Trichostatin A 可能会通过改变染色质结构和基因转录来影响 ZNF425 的表达。 | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | ¥1444.00 ¥5697.00 | 2 | |
DNA 甲基转移酶抑制剂 RG108 可能会通过 DNA 甲基化的变化间接调节 ZNF425 的表达。 | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | ¥587.00 ¥982.00 | 7 | |
二硫仑可以螯合锌离子,有可能影响锌指蛋白(如 ZNF425)的功能。 | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | ¥530.00 | ||
作为一种锌源,吡硫翁锌可能会通过调节锌的可用性间接影响 ZNF425 的功能。 | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | ¥2933.00 ¥10436.00 | 5 | |
C646 是一种 p300/CBP 组蛋白乙酰转移酶抑制剂,可通过改变组蛋白乙酰化和基因表达间接影响 ZNF425。 | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | ¥609.00 | 6 | |
DNA 结合型抗生素 Mithramycin A 可能会与 ZNF425 竞争 DNA 结合位点,从而对 ZNF425 产生影响。 | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | ¥406.00 ¥1241.00 ¥4513.00 | ||
BIX-01294 是一种 G9a 组蛋白甲基转移酶抑制剂,可能会通过改变组蛋白甲基化和染色质结构来影响 ZNF425 的表达。 | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | ¥2550.00 ¥9545.00 | 1 | |
JQ1 是一种 BET 溴域抑制剂,可能会通过调节转录因子对染色质的可及性影响 ZNF425 的活性。 | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | ¥293.00 ¥1038.00 ¥1354.00 ¥3497.00 ¥5641.00 ¥10244.00 ¥20545.00 | 46 | |
染料木素作为一种酪氨酸激酶抑制因子,可能会通过参与信号转导和转录调节的途径间接影响 ZNF425 的活性。 |